© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Equity

Top section

Top section

Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
Executive moves from Deutsche to be MD
More articles

More articles

More articles

  • Last year GlobalCapital was forced to abandon our 2019 Equity Capital Markets Awards dinner because of the Covid-19 pandemic. Little did we know that what seemed like a brief crisis would transform all our lives in the way it has. But despite the huge pressure of the virus and its dramatic impact on stockmarkets, the equity capital markets rose to the challenge in 2020, enabling many companies to raise vital capital to mend broken balance sheets and even to complete IPOs, all without executives having to leaving their home countries — or even their homes. After an extraordinary year, GlobalCapital is pleased to recognise the truly outstanding achievements in ECM.
  • SRI
    The polite world of sustainable finance has collided with the ugly reality of politics in the past week, as open strife has broken out over the European Union’s sustainable finance legislation, especially the Taxonomy. Conservative and progressive elements are battling over a host of issues, above all whether gas power should ever be classed as sustainable, and the validity and even legality of the Taxonomy is being called into question.
  • Equity investors and bankers are increasingly fearful that the European IPO market is running far too hot, with over-cooked valuations blowing an asset bubble. Investors are already overworked and have little time to give the bulging pipeline of up to 100 more IPOs the proper scrutiny they need, reports Sam Kerr.
  • Siemens Healthineers, the German healthcare tech company, has completed the second leg of equity financing to fund its acquisition of US cancer care solutions firm Varian. The involvement of a large anchor investor was revealed at the top of the book, which was quickly filled with long-only investors.
  • The US securities regulator has introduced rules that would delist foreign companies from local stock exchanges if they do not comply with US auditing standards. Shares in Chinese companies dual listed in Hong Kong and the US dived following the move.
  • Two large European IPOs reached successful conclusions on Thursday, albeit without the large aftermarket surges on deals earlier this year.
shared comment list